Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
3.330
+0.010 (0.30%)
At close: Dec 5, 2025, 4:00 PM EST
3.300
-0.030 (-0.90%)
After-hours: Dec 5, 2025, 7:58 PM EST
Gossamer Bio Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Gossamer Bio stock ranges from a low of $5.00 to a high of $11. The average analyst price target of $8.60 forecasts a 158.26% increase in the stock price over the next year.
Price Target: $8.60 (+158.26%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 10, 2025.
Analyst Ratings
The average analyst rating for Gossamer Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 11, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $1.25 → $9 | Hold → Strong Buy | Upgrades | $1.25 → $9 | +170.27% | Sep 10, 2025 |
| Wedbush | Wedbush | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +50.15% | Aug 6, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $11 | Buy | Initiates | $11 | +230.33% | Jul 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +140.24% | May 16, 2025 |
Financial Forecast
Revenue This Year
43.04M
from 114.70M
Decreased by -62.48%
Revenue Next Year
45.79M
from 43.04M
Increased by 6.41%
EPS This Year
-0.73
from -0.25
EPS Next Year
-0.59
from -0.73
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 51.6M | 126.4M | ||||
| Avg | 43.0M | 45.8M | ||||
| Low | 34.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -55.0% | 193.8% | ||||
| Avg | -62.5% | 6.4% | ||||
| Low | -70.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.62 | -0.21 | ||||
| Avg | -0.73 | -0.59 | ||||
| Low | -0.78 | -0.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.